• Ridaforolimus (Deforolimus): Applied mTOR Inhibition in Canc

  2026-05-21

  Ridaforolimus (Deforolimus, MK-8669) delivers highly selective mTOR inhibition, empowering reproducible cancer and senescence research workflows. Explore advanced protocol designs, troubleshooting strategies, and the latest machine learning-driven insights for optimizing apoptosis, antiproliferative, and angiogenesis assays.

• Nonivamide (Capsaicin Analog): TRPV1-Driven Inflammation Con

  2026-05-21

  Explore how Nonivamide, a capsaicin analog, uniquely modulates TRPV1 to control inflammation and inhibit cancer cell growth. This article delivers a deep dive into its mechanisms, translational significance, and practical guidance for advanced oncology and neuroimmune research.

• Prosapogenin A Triggers GSDME Pyroptosis via Lysosomal Acidi

  2026-05-20

  This study reveals that prosapogenin A induces GSDME-dependent pyroptosis in anaplastic thyroid cancer cells through vacuolar ATPase-mediated lysosomal over-acidification. The findings highlight a novel mechanistic link between lysosomal membrane permeabilization and cancer cell death, with implications for developing new therapeutic strategies for highly aggressive ATC.

• Caspase-4 Colorimetric Assay Kit: Decoding Pyroptosis Mechan

  2026-05-20

  Explore the Caspase-4 Colorimetric Assay Kit as an advanced colorimetric caspase assay for dissecting pyroptosis and inflammasome signaling. This article delivers a deeper mechanistic analysis and practical guidance for cutting-edge inflammation research.

• Z-WEHD-FMK: Advancing Caspase Pathway Research in Inflammati

  2026-05-19

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) enables precise, irreversible inhibition of inflammatory caspases, empowering researchers to dissect pyroptosis, apoptosis, and microbial pathogenesis with unmatched specificity. Its robust, cell-permeable profile makes it an indispensable tool for both foundational and translational inflammation research.

• Mecamylamine Hydrochloride: Innovating nAChR Antagonist Assa

  2026-05-19

  Explore how Mecamylamine hydrochloride empowers high-precision neuropsychiatric disorder research through selective nAChR antagonism. This article uniquely bridges molecular pharmacology with practical assay design, extending beyond current guides.

• Evaluating Ribociclib–Acid Reducer Interactions via QbD Anal

  2026-05-18

  This study applies a Quality by Design (QbD) framework to assess whether acid-reducing agents impact the solubility and absorption of ribociclib, a key CDK4/6 inhibitor for breast cancer therapy. The findings indicate that pH shifts from acid reducers do not significantly alter ribociclib’s pharmacokinetics, refining early-stage drug interaction assessments and clinical decision-making.

• Applied Use of Z-VEID-FMK: Precision Caspase-6 Inhibitor Wor

  2026-05-18

  Z-VEID-FMK empowers researchers with highly selective, irreversible caspase-6 inhibition for fine-tuned apoptosis assays and neurodegeneration models. Explore advanced workflows, troubleshooting strategies, and insights from the latest virology research to maximize data integrity and experimental reproducibility.

• Caspase-8 Fluorometric Assay Kit: Reliable Apoptosis Detecti

  2026-05-17

  This scenario-driven article addresses real-world laboratory challenges in apoptosis and programmed cell death research, focusing on reproducibility, sensitivity, and workflow efficiency. Drawing on published evidence and practical experience, we demonstrate how the Caspase-8 Fluorometric Assay Kit (SKU K2012) from APExBIO enables robust, quantitative caspase-8 activity measurement across oncology and neurodegenerative models.

• Carboplatin in Stem Cell-Driven Chemoresistance: Mechanisms

  2026-05-16

  Discover how Carboplatin, a platinum-based DNA synthesis inhibitor, elucidates cancer stem cell-mediated resistance in preclinical oncology research. This article uniquely explores the IGF2BP3–FZD1/7 axis and its assay implications for translational cancer models.

• GSK3 Inhibition as a Host-Directed Therapy for Tuberculosis

  2026-05-15

  The referenced iScience study demonstrates that inhibiting glycogen synthase kinase 3 (GSK3) in human macrophages restricts intracellular Mycobacterium tuberculosis growth, providing a promising host-directed alternative to antimicrobial therapy. This approach highlights the value of targeting host pathways to overcome limitations of current multi-drug resistant tuberculosis treatment strategies.

• Rottlerin as a PKC Inhibitor: Precision Tools for Viral & Ca

  2026-05-15

  Rottlerin stands out as a selective PKC inhibitor, empowering researchers to dissect clathrin-mediated viral entry and modulate apoptosis in cancer models. Explore experimental workflows, troubleshooting strategies, and protocol optimizations that unlock its full translational potential.

• TMEM16F-Mediated Lipid Scrambling: Ferroptosis and Tumor Imm

  2026-05-14

  This study reveals TMEM16F as a key suppressor of ferroptosis, demonstrating that its loss sensitizes tumor cells to ferroptotic death and enhances anti-tumor immune responses. The findings elucidate the role of plasma membrane lipid scrambling in the execution phase of ferroptosis and present new therapeutic avenues for cancer immunotherapy.

• Oteseconazole (VT-1161): Precision Antifungal Workflows & Tr

  2026-05-14

  Oteseconazole (VT-1161) sets a new standard in antifungal research, enabling robust inhibition of Candida—including fluconazole-resistant strains—while minimizing off-target effects. This guide details experimental setup, optimization strategies, and practical troubleshooting to maximize data quality and reproducibility in Candida-focused workflows.

• Microbiota–Tryptophan–AhR Axis in Ulcerative Colitis Repair

  2026-05-13

  Li et al. (2026) provide mechanistic evidence that the herbal Huangqin decoction (HQD) promotes intestinal stem cell differentiation and mucosal healing in ulcerative colitis by modulating gut microbiota, enhancing tryptophan-derived AhR ligands, and activating AhR signaling. This study clarifies a pivotal microbiota–tryptophan–AhR–stem cell pathway, offering new insights for targeted intestinal regeneration strategies.

457 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page